Pharma-Bio Serv (OTCMKTS:PBSV) Announces Earnings Results

Pharma-Bio Serv (OTCMKTS:PBSV) posted its earnings results on Monday. The company reported $0.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.02 by $0.35, reports. Pharma-Bio Serv had a negative net margin of 8.18% and a negative return on equity of 5.61%. The business had revenue of $2.47 million for the quarter, compared to analysts’ expectations of $2.70 million.

Pharma-Bio Serv Stock Performance

Pharma-Bio Serv stock opened at $0.55 on Tuesday. Pharma-Bio Serv has a one year low of $0.31 and a one year high of $0.90. The stock has a fifty day moving average of $0.55 and a 200 day moving average of $0.57. The stock has a market cap of $12.61 million, a PE ratio of -18.33 and a beta of 0.53.

Pharma-Bio Serv Announces Dividend

The company also recently disclosed a dividend, which will be paid on Thursday, March 20th. Investors of record on Friday, February 28th will be issued a $0.075 dividend. The ex-dividend date of this dividend is Friday, February 28th. Pharma-Bio Serv’s payout ratio is currently -250.00%.

About Pharma-Bio Serv

Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies.